Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 7/2007

01-07-2007 | Original Paper

Changes in pelvic and systemic platinum concentrations during negative-balance isolated pelvic perfusion: correlation between platinum concentration and method of administration in a pig model

Authors: Satoru Murata, Hiroyuki Tajima, Yutaka Abe, Shiro Onozawa, Fumio Uchiyama, Hiromitsu Hayashi, Ryoji Kimata, Kazuhiro Nomura

Published in: Journal of Cancer Research and Clinical Oncology | Issue 7/2007

Login to get access

Abstract

Purpose

To assess the effect of altering the method of administration during negative-balance isolated pelvic perfusion (NIPP) on the platinum concentration in the pelvic or systemic circulation.

Methods

Twenty female pigs were used in this study. The abdominal aorta and the infra-renal vena cava were occluded with two balloon catheters and blood in the extracorporeal circuit was circulated with twin rotary pumps. NIPP was then performed with cisplatin (5 mg/kg) in 15 pigs. Three types of NIPP administration method (group A: 1 bolus, B: 2 same doses boluses, C: 3 same doses boluses) were used, five pigs being subjected to each treatment. The remaining five pigs were administered cisplatin systemically as a control study (group D). The platinum concentrations in the pelvic and systemic circulation were measured and compared.

Results

(1) Pelvic circulation: There was a tendency for the platinum concentration to increase as the bolus time decreased. The platinum concentration in groups A and B was significantly (P < 0.05) higher than that in group C. Significant differences (P < 0.05) between groups A and B until 10 min after the start of NIPP. (2) Systemic circulation: Significant differences (P < 0.05) were observed between NIPP groups and D during NIPP. The platinum concentration in group D was five times higher than that in group C. (3) Plasma pelvic to systemic exposure ratio: there were no significant differences among the three NIPP groups.

Conclusions

The platinum concentrations in the pelvic and systemic circulation increased as the bolus time decreased. The plasma pelvic to systemic exposure ratio was not influenced by bolus time.
Literature
go back to reference Austen WA, Monaco AP, Richardson GS, Baker WH, Shaw RS, Raker JW (1959) Treatments of malignant pelvic tumors by extracorporeal perfusion with chemotherapeutic agents. N Engl J Med 261:1037–1045PubMedCrossRef Austen WA, Monaco AP, Richardson GS, Baker WH, Shaw RS, Raker JW (1959) Treatments of malignant pelvic tumors by extracorporeal perfusion with chemotherapeutic agents. N Engl J Med 261:1037–1045PubMedCrossRef
go back to reference Belliveau JF, Arevalo E, Griffin H, Wanebo HJ (2005) Isolated pelvic perfusion: plasma pharmacokinetics depend primarily on drug dosage and not the type of drug. Cancer Chemother Pharmacol 55:318–322PubMedCrossRef Belliveau JF, Arevalo E, Griffin H, Wanebo HJ (2005) Isolated pelvic perfusion: plasma pharmacokinetics depend primarily on drug dosage and not the type of drug. Cancer Chemother Pharmacol 55:318–322PubMedCrossRef
go back to reference Collins JM (1989) Pharmacologic rationale for regional drug delivery. J Clin Oncol 2:498–504 Collins JM (1989) Pharmacologic rationale for regional drug delivery. J Clin Oncol 2:498–504
go back to reference Creech O, Krementz ET, Ryan RF, Winblad JN (1958) Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 148:616–632PubMedCrossRef Creech O, Krementz ET, Ryan RF, Winblad JN (1958) Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 148:616–632PubMedCrossRef
go back to reference Guadagni S, Aigner KR, Palumbo G, Cantore M, Fiorentini G, Pozone T, Deraco M, Clerico M, Chaudhuri PK (1998) Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancer. J Clin Pharmacol 38(10):936–44PubMed Guadagni S, Aigner KR, Palumbo G, Cantore M, Fiorentini G, Pozone T, Deraco M, Clerico M, Chaudhuri PK (1998) Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancer. J Clin Pharmacol 38(10):936–44PubMed
go back to reference Lawrence W Jr, Kuehn P, Mori S (1961) Regional perfusion of the pelvis: considerations of the leakage problem. Surgery 50:248–259PubMed Lawrence W Jr, Kuehn P, Mori S (1961) Regional perfusion of the pelvis: considerations of the leakage problem. Surgery 50:248–259PubMed
go back to reference Lawrence W Jr, Clarkson B, Kim M, Clapp P, Randall HT (1963) Regional perfusion of pelvis and abdomen by an indirect technique. Cancer 16:567–582CrossRef Lawrence W Jr, Clarkson B, Kim M, Clapp P, Randall HT (1963) Regional perfusion of pelvis and abdomen by an indirect technique. Cancer 16:567–582CrossRef
go back to reference Murata S, Tajima H, Kusakai G, Kumazaki T, Abe Y, Onozawa S, Komada Y, Kondo Y, Kimata Y, Himeno S, Satake M (2005) Reduction of drug leakage by negative-balance isolated pelvic perfusion: correlation between leakage and in–out flow rate in a pig model. J Cancer Res Clin Oncol 131:575–580PubMedCrossRef Murata S, Tajima H, Kusakai G, Kumazaki T, Abe Y, Onozawa S, Komada Y, Kondo Y, Kimata Y, Himeno S, Satake M (2005) Reduction of drug leakage by negative-balance isolated pelvic perfusion: correlation between leakage and in–out flow rate in a pig model. J Cancer Res Clin Oncol 131:575–580PubMedCrossRef
go back to reference Shingleton WW, Parker RT, Mahaley S (1961) Abdominal perfusion for cancer chemotherapy with hypothermia and hyperthermia. Surgery 50:260–265 Shingleton WW, Parker RT, Mahaley S (1961) Abdominal perfusion for cancer chemotherapy with hypothermia and hyperthermia. Surgery 50:260–265
go back to reference Stehlin JS, Clark RL, White EC (1960) Regional chemotherapy for cancer: experience with 116 perfusions. Ann Surg 151:605–619PubMed Stehlin JS, Clark RL, White EC (1960) Regional chemotherapy for cancer: experience with 116 perfusions. Ann Surg 151:605–619PubMed
go back to reference Turk PS, Belliveau JF, Darnowski JW, Weinberg MC, Leenen L, Wanebo HJ (1993) Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg 128:533–539PubMed Turk PS, Belliveau JF, Darnowski JW, Weinberg MC, Leenen L, Wanebo HJ (1993) Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg 128:533–539PubMed
go back to reference Wanebo HJ, Belliveau JF (1999) A pharmacokinetic model and clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion. Cancer Chemother Pharmacol 43:427–434PubMedCrossRef Wanebo HJ, Belliveau JF (1999) A pharmacokinetic model and clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion. Cancer Chemother Pharmacol 43:427–434PubMedCrossRef
go back to reference Wanebo HJ, Chung MD, Levy AI, Turk PS, Vezeridis MP, Belliveau JF (1996) Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon occlusion technique. Ann Surg Oncol 3:295–303PubMedCrossRef Wanebo HJ, Chung MD, Levy AI, Turk PS, Vezeridis MP, Belliveau JF (1996) Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon occlusion technique. Ann Surg Oncol 3:295–303PubMedCrossRef
go back to reference Wanebo HJ, Belliveau JF, Begossi G, Levy A. (2003) Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer. Colorectal Dis 5:508–514PubMedCrossRef Wanebo HJ, Belliveau JF, Begossi G, Levy A. (2003) Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer. Colorectal Dis 5:508–514PubMedCrossRef
go back to reference Watkins E Jr, Hering AC, Luna R, Adams HD (1960) The use of intravascular balloon catheters for isolation of the pelvic bed during pump oxygenerator perfusion of cancer chemotherapeutic agents. Surg Gynecol Obstet 111:464–468PubMed Watkins E Jr, Hering AC, Luna R, Adams HD (1960) The use of intravascular balloon catheters for isolation of the pelvic bed during pump oxygenerator perfusion of cancer chemotherapeutic agents. Surg Gynecol Obstet 111:464–468PubMed
go back to reference Wile AG, Smolin M (1987) Hyperthermic pelvic isolation-perfusion in the treatment of refractory pelvic cancer. Arch Surg 122:1321–1325PubMed Wile AG, Smolin M (1987) Hyperthermic pelvic isolation-perfusion in the treatment of refractory pelvic cancer. Arch Surg 122:1321–1325PubMed
go back to reference Wile AG, Stemmer EA, Andrews PA, Murphy MP, Abramson IS, Howell SB (1985) Pharmacokinetics of 5-fluorouracil during hyperthermic pelvic isolation-perfusion. J Clin Oncol 3:849–852PubMed Wile AG, Stemmer EA, Andrews PA, Murphy MP, Abramson IS, Howell SB (1985) Pharmacokinetics of 5-fluorouracil during hyperthermic pelvic isolation-perfusion. J Clin Oncol 3:849–852PubMed
Metadata
Title
Changes in pelvic and systemic platinum concentrations during negative-balance isolated pelvic perfusion: correlation between platinum concentration and method of administration in a pig model
Authors
Satoru Murata
Hiroyuki Tajima
Yutaka Abe
Shiro Onozawa
Fumio Uchiyama
Hiromitsu Hayashi
Ryoji Kimata
Kazuhiro Nomura
Publication date
01-07-2007
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 7/2007
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-006-0168-7

Other articles of this Issue 7/2007

Journal of Cancer Research and Clinical Oncology 7/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.